Tia Bush Net Worth & Insider Trades

Tia Bush - Chief Quality Officer, Centessa Pharmaceuticals Plc

As of July 3, 2023

What is Tia Bush's Net Worth?

The current estimated net worth of Centessa Pharmaceuticals Plc's Chief Quality Officer, Tia Bush, is estimated to be about $74.53K . Tia Bush owns about 157,102 units of Centessa Pharmaceuticals Plc common stock. In the last 2 years at Centessa Pharmaceuticals Plc, Tia Bush has sold an estimated value of $143.29K worth.

What is Tia Bush's Past Insider Trading?

Tia Bush's largest purchase order was 5,000 units , worth over $62.3K on November 18, 2021. Tia Bush's largest sale order was 8,000 units , worth over $35.87K on May 26, 2023. In total, Tia Bush has made about 11 transactions over 2 years of their time at Centessa Pharmaceuticals Plc. Tia Bush usually trades in February, July and January, with the busiest year in 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Tia Bush

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Tia Bush's' Mailing Address?

  • Mailing address is C/o Centessa Pharmaceuticals Plc D. Hodgkin Bldg, Babraham Rsrch Campus Cambridge X0 CB22 3FH United Kingdom

What are Centessa Pharmaceuticals Plc's Past Insider Trades?

Centessa Pharmaceuticals Plc's most recent insider trade came on September 22, 2023 by Harris Rotman who sold 37,484 units worth $235.69K . In the last 2 years, insiders at Centessa Pharmaceuticals Plc have sold an estimated value of $2.61M and bought an estimated value of $75.29M worth of shares. Insider trading is most common in July, with the busiest year in 2023. The most active traders at the company are Antoine Yver, EVP & Chairman Development,  Tia Bush, Chief Quality Officer,  and David Grainger, Chief Innovation Officer .

Centessa Pharmaceuticals plc Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...